Production of Recombinant Biopharmaceuticals in Chlamydomonas reinhardtii

This review aimed to present Chlamydomonas reinhardtii as an alternative for heterologous protein production, especially biopharmaceuticals, and its general characteristics when compared with other expression systems. The need produce proteins industrial interest, therapeutic ends, diagnostic kits has led the development of recombinant microalgal technology. technology presents some interesting features, such rapid growth low transgene dispersion plants, ability fold complex bacteria, production costs systems, yeast mammalian cells. Overall, C. is coming age several research groups focused on developing optimal producer strain.